BackNeuroSense Therapeutics Overview

NeuroSense Therapeutics Receivables

Latest receivables for NRSN: $540K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$540000.00
↓ 36.25% YoYΔ $-307000.00 vs prior year quarter

Peer trimmed avg / median

Loading

NeuroSense Therapeutics Receivables History

Loading

NeuroSense Therapeutics vs. peers: Receivables Comparison

Loading

NeuroSense Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NeuroSense Therapeutics (NRSN) FAQ

NeuroSense Therapeutics (NRSN) currently reports a receivables of $540K as of June 2026. That compares with $850K in the prior-year period — down 36.2% year over year. Use the charts on this page to explore NeuroSense Therapeutics's receivables history and peer comparisons.

NeuroSense Therapeutics's receivables decreased from $850K to $540K — a 36.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NeuroSense Therapeutics reported $540K in receivables as of June 2026. That compares with $850K in the prior-year period — down 36.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $540K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NeuroSense Therapeutics, and consider following NRSN for alerts when major investors trade the stock.